-
Molecules (Basel, Switzerland) Apr 2022A standard goal of medicinal chemists has been to discover efficient and potent drug candidates with specific enzyme-inhibitor abilities. In this regard, boron-based... (Review)
Review
A standard goal of medicinal chemists has been to discover efficient and potent drug candidates with specific enzyme-inhibitor abilities. In this regard, boron-based bioactive compounds have provided amphiphilic properties to facilitate interaction with protein targets. Indeed, the spectrum of boron-based entities as drug candidates against many diseases has grown tremendously since the first clinically tested boron-based drug, Velcade. In this review, we collectively represent the current boron-containing drug candidates, boron-containing retinoids, benzoxaboroles, aminoboronic acid, carboranes, and BODIPY, for the treatment of different human diseases.In addition, we also describe the synthesis, key structure-activity relationship, and associated biological activities, such as antimicrobial, antituberculosis, antitumor, antiparasitic, antiprotozoal, anti-inflammatory, antifolate, antidepressant, antiallergic, anesthetic, and anti-Alzheimer's agents, as well as proteasome and lipogenic inhibitors. This compilation could be very useful in the exploration of novel boron-derived compounds against different diseases, with promising efficacy and lesser side effects.
Topics: Boranes; Boron; Boron Compounds; Bortezomib; Drug Discovery; Enzyme Inhibitors; Humans
PubMed: 35565972
DOI: 10.3390/molecules27092615 -
The Science of the Total Environment Oct 2023Boron (B) is released to terrestrial and aquatic environments through both natural and anthropogenic sources. This review describes the current knowledge on B... (Review)
Review
Boron (B) is released to terrestrial and aquatic environments through both natural and anthropogenic sources. This review describes the current knowledge on B contamination in soil and aquatic environments in relation to its geogenic and anthropogenic sources, biogeochemistry, environmental and human health impacts, remediation approaches, and regulatory practices. The common naturally occurring sources of B include borosilicate minerals, volcanic eruptions, geothermal and groundwater streams, and marine water. Boron is extensively used to manufacture fiberglass, thermal-resistant borosilicate glass and porcelain, cleaning detergents, vitreous enamels, weedicides, fertilizers, and B-based steel for nuclear shields. Anthropogenic sources of B released into the environment include wastewater for irrigation, B fertilizer application, and waste from mining and processing industries. Boron is an essential element for plant nutrition and is taken up mainly as boric acid molecules. Although B deficiency in agricultural soils has been observed, B toxicity can inhibit plant growth in soils under arid and semiarid regions. High B intake by humans can be detrimental to the stomach, liver, kidneys and brain, and eventually results in death. Amelioration of soils and water sources enriched with B can be achieved by immobilization, leaching, adsorption, phytoremediation, reverse osmosis, and nanofiltration. The development of cost-effective technologies for B removal from B-rich irrigation water including electrodialysis and electrocoagulation techniques is likely to help control the predominant anthropogenic input of B to the soil. Future research initiatives for the sustainable remediation of B contamination using advanced technologies in soil and water environments are also recommended.
Topics: Humans; Boron; Minerals; Risk Management; Soil; Water
PubMed: 37315601
DOI: 10.1016/j.scitotenv.2023.164744 -
Molecules (Basel, Switzerland) Mar 2022The search for free-standing 2D materials has been one of the most important subjects in the field of studies on 2D materials and their applications. Recently, a... (Review)
Review
The search for free-standing 2D materials has been one of the most important subjects in the field of studies on 2D materials and their applications. Recently, a free-standing monolayer of hydrogenated boron (HB) sheet has been synthesized by hydrogenation of borophene. The HB sheet is also called borophane, and its application is actively studied in many aspects. Here, we review recent studies on the electronic structures of polymorphic sheets of borophane. A hydrogenated boron sheet with a hexagonal boron frame was shown to have a semimetallic electronic structure by experimental and theoretical analyses. A tight-binding model that reproduces the electronic structure was given and it allows easy estimation of the properties of the material. Hydrogenated boron sheets with more complicated nonsymmorphic boron frames were also analyzed. Using the symmetry restrictions from the nonsymmorphic symmetry and the filling factor of hydrogenated boron sheets, the existence of a Dirac nodal line was suggested. These studies provide basic insights for research on and device applications of hydrogenated boron sheets.
Topics: Boron; Electronics; Humans
PubMed: 35335171
DOI: 10.3390/molecules27061808 -
Plant Signaling & Behavior Jul 2017Experimental work has shown that Boron (i.e., Boric acid, B) is an essential and multifunctional microelement for vascular plant development. In addition to its other... (Comparative Study)
Comparative Study Review
Experimental work has shown that Boron (i.e., Boric acid, B) is an essential and multifunctional microelement for vascular plant development. In addition to its other functions, which include xylem development and lignin biosynthesis, we now know that B is involved in phytohormone-signaling and influences the mechanical properties of intercellular pectins. From these data, we conclude that B played an important role during the evolutionary development of lignified tissues, and that it may have been involved in the evolution of vascular plant roots, as hypothesized by D. H. Lewis in 1980. Herein, we review the data pertaining to Lewis' hypothesis, present experimental results on the role of B in root (vs. rhizoid) formation in sunflower vs. a liverwort, and describe the appearance of roots in the fossil record. Open questions are addressed, notably the lack of our knowledge concerning soil microbes and their interactive roles with the micronutrient B during root formation.
Topics: Biological Evolution; Boron; Fossils; Helianthus; Hepatophyta; Plant Development; Plant Roots
PubMed: 28692333
DOI: 10.1080/15592324.2017.1320631 -
Molecules (Basel, Switzerland) May 2021The unique electron deficiency and coordination property of boron led to a wide range of applications in chemistry, energy research, materials science and the life... (Review)
Review
The unique electron deficiency and coordination property of boron led to a wide range of applications in chemistry, energy research, materials science and the life sciences. The use of boron-containing compounds as pharmaceutical agents has a long history, and recent developments have produced encouraging strides. Boron agents have been used for both radiotherapy and chemotherapy. In radiotherapy, boron neutron capture therapy (BNCT) has been investigated to treat various types of tumors, such as glioblastoma multiforme (GBM) of brain, head and neck tumors, etc. Boron agents playing essential roles in such treatments and other well-established areas have been discussed elsewhere. Organoboron compounds used to treat various diseases besides tumor treatments through BNCT technology have also marked an important milestone. Following the clinical introduction of bortezomib as an anti-cancer agent, benzoxaborole drugs, tavaborole and crisaborole, have been approved for clinical use in the treatments of onychomycosis and atopic dermatitis. Some heterocyclic organoboron compounds represent potentially promising candidates for anti-infective drugs. This review highlights the clinical applications and perspectives of organoboron compounds with the natural boron atoms in disease treatments without neutron irradiation. The main topic focuses on the therapeutic applications of organoboron compounds in the diseases of tuberculosis and antifungal activity, malaria, neglected tropical diseases and cryptosporidiosis and toxoplasmosis.
Topics: Anti-Bacterial Agents; Antiparasitic Agents; Boron; Boron Neutron Capture Therapy; Bortezomib; Brain Neoplasms; Cryptosporidiosis; Dermatitis, Atopic; Eczema; Glioblastoma; Humans; Malaria; Onychomycosis; Toxoplasmosis; Tuberculosis
PubMed: 34072937
DOI: 10.3390/molecules26113309 -
International Journal of Molecular... Aug 2022Boron (B) is considered a prebiotic chemical element with a role in both the origin and evolution of life, as well as an essential micronutrient for some bacteria,... (Review)
Review
Boron (B) is considered a prebiotic chemical element with a role in both the origin and evolution of life, as well as an essential micronutrient for some bacteria, plants, fungi, and algae. B has beneficial effects on the biological functions of humans and animals, such as reproduction, growth, calcium metabolism, bone formation, energy metabolism, immunity, and brain function. Naturally organic B (NOB) species may become promising novel prebiotic candidates. NOB-containing compounds have been shown to be essential for the symbiosis between organisms from different kingdoms. New insights into the key role of NOB species in the symbiosis between human/animal hosts and their microbiota will influence the use of natural B-based colon-targeting nutraceuticals. The mechanism of action (MoA) of NOB species is related to the B signaling molecule (autoinducer-2-borate (AI-2B)) as well as the fortification of the colonic mucus gel layer with NOB species from B-rich prebiotic diets. Both the microbiota and the colonic mucus gel layer can become NOB targets. This paper reviews the evidence supporting the essentiality of the NOB species in the symbiosis between the microbiota and the human/animal hosts, with the stated aim of highlighting the MoA and targets of these species.
Topics: Animals; Bacteria; Boron; Humans; Microbiota; Plants; Prebiotics; Symbiosis
PubMed: 36012416
DOI: 10.3390/ijms23169147 -
International Journal of Molecular... Feb 2023Drug delivery systems, which use components at the nanoscale level as diagnostic tools or to release therapeutic drugs to particular target areas in a regulated manner,... (Review)
Review
Drug delivery systems, which use components at the nanoscale level as diagnostic tools or to release therapeutic drugs to particular target areas in a regulated manner, are a fast-evolving field of science. The active pharmaceutical substance can be released via the drug delivery system to produce the desired therapeutic effect. The poor bioavailability and irregular plasma drug levels of conventional drug delivery systems (tablets, capsules, syrups, etc.) prevent them from achieving sustained delivery. The entire therapy process may be ineffective without a reliable delivery system. To achieve optimal safety and effectiveness, the drug must also be administered at a precision-controlled rate and the targeted spot. The issues with traditional drug delivery are overcome by the development of stimuli-responsive controlled drug release. Over the past decades, regulated drug delivery has evolved considerably, progressing from large- and nanoscale to smart-controlled drug delivery for several diseases. The current review provides an updated overview of recent developments in the field of stimuli-responsive boron-based materials in drug delivery for various diseases. Boron-containing compounds such as boron nitride, boronic acid, and boron dipyrromethene have been developed as a moving field of research in drug delivery. Due to their ability to achieve precise control over drug release through the response to particular stimuli (pH, light, glutathione, glucose or temperature), stimuli-responsive nanoscale drug delivery systems are attracting a lot of attention. The potential of developing their capabilities to a wide range of nanoscale systems, such as nanoparticles, nanosheets/nanospheres, nanotubes, nanocarriers, microneedles, nanocapsules, hydrogel, nanoassembly, etc., is also addressed and examined. This review also provides overall design principles to include stimuli-responsive boron nanomaterial-based drug delivery systems, which might inspire new concepts and applications.
Topics: Boron; Stimuli Responsive Polymers; Drug Delivery Systems; Nanoparticles; Nanospheres; Nanocapsules; Drug Carriers; Drug Liberation
PubMed: 36769081
DOI: 10.3390/ijms24032757 -
Romanian Journal of Morphology and... 2022Research on the use of boron (B) in the field of oral health has gained momentum in recent years, with various studies on the possibilities of using various B-containing... (Review)
Review
Research on the use of boron (B) in the field of oral health has gained momentum in recent years, with various studies on the possibilities of using various B-containing compounds (BCCs). A multitude of applications have been discovered, from cariostatic activity to anti-inflammatory and antifungal activity, paving the way for other new research directions. B is a microelement that is commonly found in the human diet, and present throughout the body, with the highest concentration in the structure of bones, teeth, and gastrointestinal mucus gel layer. Multiple studies have demonstrated that B plays some important roles, especially in bone development and recently has been proposed to have an essential role in the healthy symbiosis. In addition, B has also attracted the interest of researchers, as various studies used BCCs in conventional or modern biomaterials. In this review, we have brought together the information we have found about B updates in the dental field and analyzing its future perspectives and potential for further studies.
Topics: Humans; Boron; Boron Compounds; Biocompatible Materials; Tooth; Dentistry
PubMed: 36588485
DOI: 10.47162/RJME.63.3.01 -
Angewandte Chemie (International Ed. in... Jun 2012The chemistry of organoboron compounds has been primarily dominated by their use as powerful reagents in synthetic organic chemistry. Recently, the incorporation of... (Review)
Review
The chemistry of organoboron compounds has been primarily dominated by their use as powerful reagents in synthetic organic chemistry. Recently, the incorporation of boron as part of a functional target structure has emerged as a useful way to generate diversity in organic compounds. A commonly applied strategy is the replacement of a CC unit with its isoelectronic BN unit. In particular, the BN/CC isosterism of the ubiquitous arene motif has undergone a renaissance in the past decade. The parent molecule of the 1,2-dihydro-1,2-azaborine family has now been isolated. New mono- and polycyclic B,N heterocycles have been synthesized for potential use in biomedical and materials science applications. This review is a tribute to Dewar's first synthesis of a monocyclic 1,2-dihydro-1,2-azaborine 50 years ago and discusses recent advances in the synthesis and characterization of heterocycles that contain carbon, boron, and nitrogen.
Topics: Aza Compounds; Boron
PubMed: 22644658
DOI: 10.1002/anie.201200063 -
Cancer Communications (London, England) Jun 2018Boron neutron capture therapy (BNCT) is a binary radiotherapeutic modality based on the nuclear capture and fission reactions that occur when the stable isotope,... (Review)
Review
Boron neutron capture therapy (BNCT) is a binary radiotherapeutic modality based on the nuclear capture and fission reactions that occur when the stable isotope, boron-10, is irradiated with neutrons to produce high energy alpha particles. This review will focus on tumor-targeting boron delivery agents that are an essential component of this binary system. Two low molecular weight boron-containing drugs currently are being used clinically, boronophenylalanine (BPA) and sodium borocaptate (BSH). Although they are far from being ideal, their therapeutic efficacy has been demonstrated in patients with high grade gliomas, recurrent tumors of the head and neck region, and a much smaller number with cutaneous and extra-cutaneous melanomas. Because of their limitations, great effort has been expended over the past 40 years to develop new boron delivery agents that have more favorable biodistribution and uptake for clinical use. These include boron-containing porphyrins, amino acids, polyamines, nucleosides, peptides, monoclonal antibodies, liposomes, nanoparticles of various types, boron cluster compounds and co-polymers. Currently, however, none of these have reached the stage where there is enough convincing data to warrant clinical biodistribution studies. Therefore, at present the best way to further improve the clinical efficacy of BNCT would be to optimize the dosing paradigms and delivery of BPA and BSH, either alone or in combination, with the hope that future research will identify new and better boron delivery agents for clinical use.
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Humans; Isotopes; Liposomes; Neoplasms; Neutrons; Tissue Distribution
PubMed: 29914561
DOI: 10.1186/s40880-018-0299-7